all report title image
  • Published In : Sep 2023
  • Code : CMI3557
  • Pages : 164
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
Ingographics Image

Saudi Arabia pharmaceutical drugs market growth is driven by various factors such as population growth, investment of companies in halal pharmaceuticals, decrease in fertility rates, and increase in life expectancy. The market is witnessing increasing investments by major market players and is also witnessing collaborations of several local and international companies with local generic manufacturers. Such factors are expected to facilitate robust, stable, and organic growth of Saudi Arabia pharmaceutical drugs market over the forecast period.

Market Dynamics

The major companies operating in Saudi Arabia pharmaceutical drugs market are focused on adopting strategies such as collaborations and partnerships for the development of drugs, R&D activities, and geographic expansions, this is expected to boost the Saudi Arabia pharmaceutical drugs market growth. For instance, in May 2016, GE Healthcare entered into a vaccine collaboration with the National Industrial Clusters Development Program (NICDP) under the Ministry of Energy, Industry and Mineral Resources, SaudiVax, and King Saud University, to enable vaccine self-sufficiency and pandemic preparedness in the Kingdom of Saudi Arabia (KSA).

Increasing prevalence of diabetes and cancer, in both male and female Arab population is expected to increase the growth of the Saudi Arabia pharmaceutical drugs market over the forecast period. For instance, according to the World Health Organization (WHO), 2019 report, Saudi Arabia recorded the second highest diabetes prevalence in the Middle East region while it recorded the seventh highest diabetes prevalence rate in the world. It is estimated that around 7 million of the population is diabetic and around 3 million people have pre-diabetes.

Moreover, according to the report of Globocan 2018 by WHO, the total number of new cases of cancer in both the sexes were 24,485 (across all ages) in Saudi Arabia in 2018. As per the same source, colorectal cancer was observed in the majority of males detected with cancer while breast cancer was observed in majority of women diagnosed with cancer.”

Key features of the study:

  • This report provides an in-depth analysis of Saudi Arabia pharmaceutical drugs market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the Saudi Arabia pharmaceutical drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Pfizer Inc., Sanofi S. A., GlaxoSmithKline Plc., AstraZeneca Plc, Baxter International Inc., Life Care Group of Pharmacies, Tadawi Pharmacies, Planet Pharmacies (Zahrat Al Rawdah), Al-Safwwa Pharmacy, Al Nahdi Medical, Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), Tabuk Pharmaceuticals, Hikma Pharmaceuticals PLC, Jamjoom Pharmaceuticals Co., and Julphar.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The Saudi Arabia pharmaceutical drugs market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the Saudi Arabia pharmaceutical drugs market

Detailed Segmentation:

  • Saudi Arabia Pharmaceutical Drugs Market, By Drug Type:
    • Generic Drugs
    • Branded Drugs
  • Saudi Arabia Pharmaceutical Drugs Market, By Product Type:
    • Prescription Drugs
    • Over-the-counter (OTC) Drugs
  • Saudi Arabia Pharmaceutical Drugs Market, By Application:
    • Cardiovascular
    • Musculoskeletal
    • Oncology
    • Anti-infective
    • Metabolic Disorder
    • Central Nervous System
    • Gastrointestinal
    • Respiratory
    • Hematology
    • Dermatology
    • Ophthalmology
    • Others (Nutraceutical, Dental and Veterinarian )
  • Saudi Arabia Pharmaceutical Drugs Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Company Profiles
    • Pfizer, Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Sanofi S. A.
    • GlaxoSmithKline Plc.
    • AstraZeneca Plc
    • Baxter International Inc.
    • Life Care Group of Pharmacies
    • Tadawi Pharmacies
    • Planet Pharmacies (Zahrat Al Rawdah)
    • Al-Safwwa Pharmacy
    • Al Nahdi Medical
    • Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
    • Tabuk Pharmaceuticals
    • Hikma Pharmaceuticals PLC
    • Jamjoom Pharmaceuticals Co.
    • Julphar

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Test Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Saudi Arabia Pharmaceutical Drugs Market - COVID-19 Impact Analysis
    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand
  5. Saudi Arabia Pharmaceutical Drugs Market, By Drug Type, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018-2030
      • Segment Trends
    • Generic Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Branded Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
  6.  Saudi Arabia Pharmaceutical Drugs Market, By Product Type, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018-2030
      • Segment Trends
    • Prescription Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Over-the-counter (OTC) Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
  7. Saudi Arabia Pharmaceutical Drugs Market, By Application, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 - 2030
      • Segment Trends
    • Cardiovascular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Musculoskeletal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Anti-infective
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Metabolic Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Central Nervous System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Gastrointestinal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Respiratory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Dermatology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Ophthalmology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
      • Segment Trends
  8. Saudi Arabia Pharmaceutical Drugs Market, By Distribution Channel, 2018 - 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2018 - 2030
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
  9. Competitive Landscape
    • Company Profiles
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sanofi S. A.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Daewoong Pharmaceutical Co.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • GlaxoSmithKline Plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AstraZeneca Plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Astellas Pharma
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Tadawi Pharmacies
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Planet Pharmacies (Zahrat Al Rawdah)
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Al-Safwwa Pharmacy
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Al Nahdi Medical
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Tabuk Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Hikma Pharmaceuticals PLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Jamjoom Pharmaceuticals Co
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Julphar
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Biocon Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • BeiGene
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  10. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 24 market data tables and 18 figures on “Saudi Arabia Pharmaceutical Drugs Market” - Global forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
  • Want to Buy a Report but have a Limited Budget?

    We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

    Request Discount
Logo

Reliability and Reputation

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo